## **Core Concept**
Goodpasture's syndrome is a rare autoimmune disorder characterized by the presence of anti-glomerular basement membrane (anti-GBM) antibodies. It primarily affects the kidneys and lungs, leading to rapidly progressive glomerulonephritis and pulmonary hemorrhage. The condition is named after the American pathologist Ernest Goodpasture.

## **Why the Correct Answer is Right**
The correct answer involves the presence of anti-glomerular basement membrane (anti-GBM) antibodies. In Goodpasture's syndrome, these autoantibodies specifically target the type IV collagen in the glomerular and alveolar basement membranes. This leads to inflammation and damage in the kidneys (manifesting as rapidly progressive glomerulonephritis) and lungs (manifesting as pulmonary hemorrhage). The pathogenic role of anti-GBM antibodies is well established, making this the hallmark of Goodpasture's syndrome.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although immune complex deposition is a feature of many glomerulonephritides, Goodpasture's syndrome is specifically characterized by the presence of anti-GBM antibodies, not immune complexes.
- **Option B:** This option is incorrect as it refers to ANCA-associated vasculitis, which is a different condition. ANCA (Anti-Neutrophil Cytoplasmic Antibodies) are associated with granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) and other vasculitides, not Goodpasture's syndrome.
- **Option D:** This option is incorrect because, while Goodpasture's syndrome does involve the lungs and kidneys, the defining characteristic is the presence of anti-GBM antibodies, not just the organ involvement.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Goodpasture's syndrome often presents with a combination of renal and pulmonary symptoms, such as hematuria, proteinuria, and pulmonary hemorrhage. A high index of suspicion is required for early diagnosis, which can be confirmed by detecting anti-GBM antibodies. Early treatment with plasmapheresis and immunosuppression can significantly improve outcomes.

## **Correct Answer:** C. Presence of anti-glomerular basement membrane (anti-GBM) antibodies.